Fund BasicsSee More
- Fund Family ETF Managers Group
- Assets Under Management 52,250,500
- Shares Outstanding, K 1,550
- 60-Month Beta 2.36
- Price/Earnings ttm 0.00
- Annual Dividend & Yield 0.29
- Most Recent Dividend 0.285
- Management Fee 0.68%
|Period||Period Low||Period High||Performance|
| || |
-7.96 (-19.10%)since 02/04/21
| || |
+0.22 (+0.66%)since 12/04/20
The first month of 2021 was pretty volatile. While stocks were at their all-time highs in first part of January, some downbeat economic data points as well as the retail trading frenzy in some specific...
The three indices logged in their worst week since October, dropping more than 3% each, sending the Dow Jones and S&P 500 into the red for the first month of 2021.
Simple profit-booking and some warnings from the too-big-to-fail companies probably led to crash in Wall Street last week.
Investors are closely tracking the progress in coronavirus vaccine development amid the pandemic's renewed resurgence with multiple mutants.
Positive coronavirus vaccine update from Moderna (MRNA) has hogged investors' attention.
The first half of 2021 is expected to continue bearing the brunt of the coronavirus outbreak. Thus, a COVID-themed ETF could be a smart pick.
The S&P 500, the Dow Jones and the Nasdaq Composite -- all three indexes touched all-time closing highs to end last week.
The rest of 2020 and the beginning of 2021 are expected to continue bearing the brunt of the coronavirus outbreak. Thus, a COVID-themed ETF could be a smart pick.
Positive coronavirus vaccine progress from Moderna (MRNA) has hogged investors' attention.
The remainder of 2020 is expected to continue bearing the brunt of the coronavirus outbreak and therefore, a COVID-19-themed ETF could be a smart pick.
|3rd Resistance Point||37.04|
|2nd Resistance Point||36.13|
|1st Resistance Point||34.92|
|1st Support Level||32.80|
|2nd Support Level||31.89|
|3rd Support Level||30.68|